These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32422680)

  • 1. Thr90Ser Mutation in Antithrombin is Associated with Recurrent Thrombosis in a Heterozygous Carrier.
    Lu Y; Villoutreix BO; Biswas I; Ding Q; Wang X; Rezaie AR
    Thromb Haemost; 2020 Jul; 120(7):1045-1055. PubMed ID: 32422680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of latent antithrombin in plasma from patients with antithrombin deficiency.
    de la Morena-Barrio M; Sandoval E; Llamas P; Wypasek E; Toderici M; Navarro-Fernández J; Rodríguez-Alen A; Revilla N; López-Gálvez R; Miñano A; Padilla J; de la Morena-Barrio B; Cuesta J; Corral J; Vicente V
    Thromb Haemost; 2017 May; 117(5):880-888. PubMed ID: 28229161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a New Mechanism of Antithrombin Deficiency Hardly Detected by Current Methods: Duplication of SERPINC1 Exon 6.
    de la Morena-Barrio B; de la Morena-Barrio ME; Padilla J; Teruel-Montoya R; Asenjo S; Wypasek E; Undas A; Miñano A; Vicente V; Corral J
    Thromb Haemost; 2018 May; 118(5):939-941. PubMed ID: 29564838
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombin III deficiency in Indian patients with deep vein thrombosis: identification of first India based AT variants including a novel point mutation (T280A) that leads to aggregation.
    Bhakuni T; Sharma A; Rashid Q; Kapil C; Saxena R; Mahapatra M; Jairajpuri MA
    PLoS One; 2015; 10(3):e0121889. PubMed ID: 25811371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of natural SERPINC1 mutations on ex vivo thrombin generation.
    Alhenc-Gelas M; Canonico M; Picard V
    J Thromb Haemost; 2010 Apr; 8(4):845-8. PubMed ID: 20088933
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithrombin deficiency in three Japanese families: one novel and two reported point mutations in the antithrombin gene.
    Maruyama K; Morishita E; Karato M; Kadono T; Sekiya A; Goto Y; Sato T; Nomoto H; Omi W; Tsuzura S; Imai H; Asakura H; Ohtake S; Nakao S
    Thromb Res; 2013 Aug; 132(2):e118-23. PubMed ID: 23809926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting antithrombin in health and disease, congenital deficiencies and genetic variants, and laboratory studies on α and β forms.
    Amiral J; Seghatchian J
    Transfus Apher Sci; 2018 Apr; 57(2):291-297. PubMed ID: 29784539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk.
    Rossi E; Chiusolo P; Za T; Marietti S; Ciminello A; Leone G; De Stefano V
    Thromb Haemost; 2007 Sep; 98(3):695-7. PubMed ID: 17849067
    [No Abstract]   [Full Text] [Related]  

  • 9. Dissociation of heparin-dependent thrombin and factor Xa inhibitory activities of antithrombin-III by mutations in the reactive site.
    Theunissen HJ; Dijkema R; Grootenhuis PD; Swinkels JC; de Poorter TL; Carati P; Visser A
    J Biol Chem; 1993 Apr; 268(12):9035-40. PubMed ID: 8473344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin-III-Hamilton, Ala 382 to Thr: an antithrombin-III variant that acts as a substrate but not an inhibitor of alpha-thrombin and factor Xa.
    Austin RC; Rachubinski RA; Ofosu FA; Blajchman MA
    Blood; 1991 May; 77(10):2185-9. PubMed ID: 2029579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound heterozygous mutations identified in severe type I protein S deficiency impaired the secretion of protein S.
    Zhou J; Shen W; Gu Y; Li M; Shen W
    J Clin Pathol; 2020 Jan; 73(1):7-13. PubMed ID: 31422373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory regions of SERPINC1 gene: identification of the first mutation associated with antithrombin deficiency.
    de la Morena-Barrio ME; Antón AI; Martínez-Martínez I; Padilla J; Miñano A; Navarro-Fernández J; Águila S; López MF; Fontcuberta J; Vicente V; Corral J
    Thromb Haemost; 2012 Mar; 107(3):430-7. PubMed ID: 22234719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial and venous thrombosis and prothrombotic fibrin clot phenotype in a Polish family with type 1 antithrombin deficiency (antithrombin Krakow).
    Celinska-Lowenhoff M; Iwaniec T; Alhenc-Gelas M; Musial J; Undas A
    Thromb Haemost; 2011 Aug; 106(2):379-81. PubMed ID: 21655678
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombin: in control of coagulation.
    Quinsey NS; Greedy AL; Bottomley SP; Whisstock JC; Pike RN
    Int J Biochem Cell Biol; 2004 Mar; 36(3):386-9. PubMed ID: 14687916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin heparin binding site deficiency: A challenging diagnosis of a not so benign thrombophilia.
    Orlando C; Heylen O; Lissens W; Jochmans K
    Thromb Res; 2015 Jun; 135(6):1179-85. PubMed ID: 25837307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis should be included in clinical practice when screening for antithrombin deficiency.
    Zeng W; Tang L; Jian XR; Li YQ; Guo T; Wang QY; Liu H; Wu YY; Cheng ZP; Hu B; Lu X; Yu JM; Deng J; Wang HF; Sun CY; Yang Y; Hu Y
    Thromb Haemost; 2015 Feb; 113(2):262-71. PubMed ID: 25298121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residues Tyr253 and Glu255 in strand 3 of beta-sheet C of antithrombin are key determinants of an exosite made accessible by heparin activation to promote rapid inhibition of factors Xa and IXa.
    Izaguirre G; Olson ST
    J Biol Chem; 2006 May; 281(19):13424-13432. PubMed ID: 16517611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.
    Luxembourg B; Pavlova A; Geisen C; Spannagl M; Bergmann F; Krause M; Alesci S; Seifried E; Lindhoff-Last E
    Thromb Haemost; 2014 Feb; 111(2):249-57. PubMed ID: 24196373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism.
    Martínez-Martínez I; Navarro-Fernández J; Østergaard A; Gutiérrez-Gallego R; Padilla J; Bohdan N; Miñano A; Pascual C; Martínez C; de la Morena-Barrio ME; Aguila S; Pedersen S; Kristensen SR; Vicente V; Corral J
    Blood; 2012 Jul; 120(4):900-4. PubMed ID: 22498748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis.
    Raja SM; Chhablani N; Swanson R; Thompson E; Laffan M; Lane DA; Olson ST
    J Biol Chem; 2003 Apr; 278(16):13688-95. PubMed ID: 12591924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.